Novartis Bioventures Ltd Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Novartis Bioventures Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Novartis Bioventures Ltd. Novartis Bioventures Ltd is a 10% Owner in Marina Biotech, Inc. ($MRNA) and a 10% Owner in Altimmune, Inc. ($PIP) and a 10% Owner in Tokai Pharmaceuticals Inc ($TKAI) and a 10% Owner in AILERON THERAPEUTICS INC ($ALRN) and a 10% Owner in Aerpio Pharmaceuticals, Inc. ($ZETAII) and a 10% Owner in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and a 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and a 10% Owner in Akebia Therapeutics, Inc. ($AKBA) and a in Galera Therapeutics, Inc. ($GRTX) and a 10% Owner in Galera Therapeutics, Inc. ($GRTX) and a in Aeglea BioTherapeutics, Inc. ($AGLE) and a 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and a 10% Owner in BICYCLE THERAPEUTICS plc ($BCYC).
Address: 131 FRONT STREET HAMILTON HM 12Bermuda
Companies in which Novartis Bioventures Ltd is an Insider
Adhera Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd: 10% Owner
Holdings: 2,495,065 shares
Current Value: $499,013
Latest Transaction: Jan 27 2011
$ATRX Market Capitalization: $626850.00
$ATRX Previous Close: $0.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Aeglea BioTherapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd:
Holdings: 2,175,314 shares
Current Value: $9,114,566
Latest Transaction: May 14 2018
$AGLE Market Capitalization: $56.54M
$AGLE Previous Close: $4.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Aerpio Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd: 10% Owner
Holdings: 4,188,508 shares
Latest Transaction: Apr 29 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AILERON THERAPEUTICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd: 10% Owner
Holdings: 2,100,004 shares
Latest Transaction: Apr 02 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Akebia Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd: 10% Owner
Holdings: 3,405,764 shares
Current Value: $33,648,948
Latest Transaction: Mar 27 2014
$AKBA Market Capitalization: $177.33M
$AKBA Previous Close: $9.88
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Altimmune, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd: 10% Owner
Holdings: 8,345,145 shares
Current Value: $11,432,849
Latest Transaction: Sep 14 2018
$ALT Market Capitalization: $76.74M
$ALT Previous Close: $1.37
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BICYCLE THERAPEUTICS plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd: 10% Owner
Holdings: 893,195 shares
Latest Transaction: May 30 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Eledon Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd: 10% Owner
Holdings: 4,493,458 shares
Current Value: $4,089,047
Latest Transaction: Jul 17 2015
$ELDN Market Capitalization: $20.25M
$ELDN Previous Close: $0.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Galera Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd:
Holdings: 3,469,273 shares
Latest Transaction: Jun 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ra Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd: 10% Owner
Holdings: 2,254,677 shares
Current Value: $40,967,481
Latest Transaction: Jun 20 2017
$RARX Market Capitalization: $405.38M
$RARX Previous Close: $18.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
YUMANITY THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd: 10% Owner
Holdings: 1,873,791 shares
Current Value: $27,882,010
Latest Transaction: Feb 17 2016
$YMTX Market Capitalization: $367.66M
$YMTX Previous Close: $14.88
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Novartis Bioventures Ltd
Sentiment: All, ATRX, AGLE, ARPO, ALRN, AKBA, ALT, BCYC, ELDN, GRTX, RARX, YMTX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | Sell | S | 8.25 | 1,001,312 | 8,260,824 | 2,467,961 | 3.5 M to 2.5 M (-28.86 %) | |
| Jun 22 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | Sell | S | 9.04 | 900 | 8,136 | 3,469,273 | 3.5 M to 3.5 M (-0.03 %) | |
| Jun 22 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | Sell | S | 8.25 | 1,001,312 | 8,260,824 | 2,467,961 | 3.5 M to 2.5 M (-28.86 %) | |
| Jun 22 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | Sell | S | 9.04 | 900 | 8,136 | 3,469,273 | 3.5 M to 3.5 M (-0.03 %) | |
| Jun 17 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.27 | 4,622 | 42,846 | 3,470,173 | 3.5 M to 3.5 M (-0.13 %) |
| Jun 17 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.30 | 8,600 | 79,980 | 3,474,795 | 3.5 M to 3.5 M (-0.25 %) |
| Jun 17 2020 | GRTX | Galera Therapeutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 9.05 | 6,164 | 55,784 | 3,483,395 | 3.5 M to 3.5 M (-0.18 %) |